Navigation Links
CNS Response Announces Fiscal Third Quarter 2007 Results
Date:8/19/2007

NS Response is also an aide to pharmaceutical developers, who can use rEEG(SM) to (1) stratify study populations to improve the success of FDA clinical trials; (2) provide insight on effective therapeutic dosing of investigational drugs; (3) identify additional indications for psychiatric medications; (4) provide insight into effective drug combinations; and (5) discover opportunities for decision analytics and support. In addition to these applications, CNS Response continues to investigate the use of rEEG analysis for development of proprietary pharmaceutical opportunities.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements involve risks and uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.

Contacts:

Investor Relations:

Sara Ephraim

(646) 536-7002

sephraim@theruthgroup.com

Media:

Janine McCargo / Jason Rando

(646) 536-7033 / 7025

jmccargo@theruthgroup.com

jrando@theruthgroup.com


'/>"/>
SOURCE CNS Response, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3

Related biology technology :

1. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
2. FLIPR Calcium 3 Assay Kit - An Optimal No-Wash Fluorescence Calcium Indicator Reagent for Non-Optimal Calcium Responses
3. IT critical in pandemic response, but many are not paying attention
4. Quick response manufacturing and biotech
5. Speaker announces business members of IT Task Force
6. Doyle announces technology tax credits for Berbee
7. Doyle announces new energy, global warming policies
8. Doyle announces $80M renewable energy strategy
9. GE announces first installation of Discovery VCT
10. UWM announces winners of RGI awards
11. Third Wave announces two senior management appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)HOUSTON, Dec. 3 JourneyLite of Houston, LLC announced today that it has updated its facility to offer patients a second surgical option, vertical sleeve gastrectomy , along with the LAP-BAND®
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Carbondioxide Incubators - A Global Market Perspective ,, http://www.reportlinker.co
Breaking Biology Technology:JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...ciences, Inc.,(OTC Bulletin Board: DSCI), a provid...s increased its direct-sales staff significantly, ... favor in target markets. The,company, which had o...now,has nine, and will move to 21 by 2009. The inc...ch has been growing sales at an accelerating rate,...
...t 7:00 p.m. Eastern Time in Conjunction with ...e - REDWOOD CITY, Calif. and SUNNYVALE, Calif.,...tive,Surgical, Inc. (Nasdaq: ISRG ) today announc...c of "Advanced Techniques and Technologies in Robo...pair." The symposium will,feature Intuitive,s da V...
...tinue pre-adoption clinical evaluation of ...CJD now means that all the population is susceptib... Increased concerns over "second wave" of vCJD in ...r incubation times - P-Capt(R) prion reduction f... against potential transmission of the disease in ...
Other Biology Technology:Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 2Derma Sciences Expands Direct Sales Force for Advanced Wound Care, Looks to Double Again in 2008 3Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 2Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 3Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 4Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair' 5ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 2ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 3ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 4ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies 5
(Date:12/3/2009)The extinction of plant and animal species can be likened to emptying a museum of its collection, or dumping a cabinet full of potential medicines into the trash, or replacing every local cuisine with
(Date:12/3/2009)PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal
(Date:12/3/2009)Coral reef fish can undergo a personality change in warmer water, according to an intriguing new study suggesting that climate change may make some species more aggressive. , Experiments with two spe
Breaking Biology News(10 mins):Species down, disease up 2Species down, disease up 3Species down, disease up 4CTRC-AACR San Antonio Breast Cancer Symposium continues to expand 2Fish with attitude: Some like it hot 2WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 1WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 2WellGen Recognized as Nutraceutical 26amp 3B 238220 3BInnovator 26amp 3B 238221 3B by Global Business Insights 14888 3Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 1Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 2Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 3Texas Laparoscopic Consultants Profiled on ABC 13 TV as the Only Practice in Houston Offering Single Incision Quick Recovery Weight Loss Surgery 61594 4AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 1AMA Optics Announces New Brightness Acuity Meter Documents Disabling Glare from Cataract 61591 2
...ifficult to eliminate tumours effectively. Deciph...e immune system,s effect on tumour cells and thus ...mmune therapy. At the Institut Curie, INSERM and ...o demonstrate, for the first time in vivo and real... in order to fight it. , These "defenders" methodi...
...n examine single molecules in order to determine g...ore accurately examine single cancer cells, has be...rchers at UCLA,s California Nanosystems Institute...f Mathematical Sciences, and Veeco Instruments, a ...January issue of the journal Nanotechnology. , Pr...
... have discovered that the same ingredient used in ...d flaking on your head also can calm overexcited n... treatment for seizures. Results of the study can ...lepsy and other seizure disorders result when nerv...in. The brain’s “off?switches fail in part due to ...
Other Biology News:How T lymphocytes attack 2How T lymphocytes attack 3Anti-dandruff compound may help fight epilepsy 2
Corning Culture Flask, 25 cm2, Tc-Treated, Angled Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
LIC Duet™ T7•Tag® Ek Adaptor from Novagen
Corning Culture Flask, 75 cm2, Tc-Treated, Straight Neck, Phenolic-Style Cap, Sterile from Sigma-Aldrich
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Novus Biologicals
Biology Products: